M&A Deal Summary

QHP Capital Acquires Applied StemCell

On October 9, 2023, private equity firm QHP Capital acquired life science company Applied StemCell from Hermed Capital

Acquisition Highlights
  • This is QHP Capital’s 5th transaction in the Life Science sector.
  • This is QHP Capital’s 11th transaction in the United States.
  • This is QHP Capital’s 1st transaction in California.

M&A Deal Summary

Date 2023-10-09
Target Applied StemCell
Sector Life Science
Buyer(s) QHP Capital
Sellers(s) Hermed Capital
Deal Type Secondary Buyout
Advisor(s) Baird (Financial)

Target

Applied StemCell

Milpitas, California, United States
Applied StemCell is a biotechnology company. ASC offers an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications. Applied StemCell was established in 2008 and is based in Milpitas, California.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

DESCRIPTION

QHP Capital is a private equity firm focused on healthcare businesses in the middle-market. Specific areas of interest include tech-enabled life sciences and pharma service companies. The Firm seeks to partner with management teams in founder or family-owned companies, and invests in buyouts and other transaction types. QHP Capital was founded in 2022 and is headquartered in Raleigh, North Carolina.


DEAL STATS #
Overall 11 of 11
Sector (Life Science) 5 of 5
Type (Secondary Buyout) 3 of 3
State (California) 1 of 1
Country (United States) 11 of 11
Year (2023) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-10 COPILOT

Maitland, Florida, United States

COPILOT is a digital-first patient-centric reimbursement hub services platform intended to support the relationship between patients, healthcare providers and pharmaceutical and device manufacturers. COPILOT was founded in 2010 and is based in Maitland, Florida.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-06-12 Pro-ficiency

Raleigh, North Carolina, United States

Pro-ficiency is an eLearning provider of tech-enabled training and compliance solutions for clinical trials. The Company provides a comprehensive suite of services, including a turn-key offering of customized, virtual training simulations, training, and compliance monitoring tools, and real-time data & predictive analytics. Pro-ficiency was founded in 2014 and is based in Raleigh, North Carolina.

Sell $100M

Seller(S) 1

DESCRIPTION

Hermed Capital is a private investment firm focused on the healthcare sector. Specific areas of interest include pharmaceuticals, medical devices & diagnostics, and medical services. Hermed Capital was formed in 2015 and is headquartered in Shanghai


DEAL STATS #
Overall 3 of 3
Sector (Life Science) 3 of 3
Type (Secondary Buyout) 1 of 1
State (California) 2 of 2
Country (United States) 2 of 2
Year (2023) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-12 Hinova Pharmaceuticals

Chengdu, China

Hinova Pharmaceuticals engages in the development and production of drugs in the therapeutic areas of tumors and metabolic diseases. It develops drugs based on technology platforms, such as deuterium and PROTAC. Hinova Pharmaceuticals was founded in 2013 and is based in Chengdu, China.

Sell -